Communiqués de presse

With a promising future, VitamFero improves its resources with the addition of Didier Roy to its ranks.

2012/07/25

VitamFero, a biotechnology firm in the Genopole® cluster with a secondary base in Tours (Indre & Loire, France) and that develops new vaccines against specific parasitic diseases, announces the addition to its ranks of Didier Roy as Director of Development.

pdf

Previous page | Top

  • Print
  • Send this article by mail
Latest News

Genethon receives approval from the UK medicine regulatory agency to start a new clinical trial for an inherited immune (...)

icône PDF

VitamFero signs agreement with Merial to develop new production animal antiparasitic vaccines

icône PDF

Progeria: Discovery of a molecular mechanism that protects neurons from premature aging

icône PDF

VitamFero increases its assets with excellent results for two of its veterinary candidates

icône PDF
Location map - Dowload available documents